M. Sweeney, Lacie A Gunnett, D. Mohan Kumar, B. Lunt, Lucina Galina Pantoja, D. Bade, Chandra M. Machin
{"title":"2016 - 2020年美国和加拿大病猪分离胸膜肺炎放线杆菌、支气管脓毒杆菌、多杀性巴氏杆菌和猪链球菌的药敏分析","authors":"M. Sweeney, Lacie A Gunnett, D. Mohan Kumar, B. Lunt, Lucina Galina Pantoja, D. Bade, Chandra M. Machin","doi":"10.54846/jshap/1282","DOIUrl":null,"url":null,"abstract":"Objective: To report the in vitro susceptibility to veterinary antimicrobial agents of Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, and Streptococcus suis isolated from diseased pigs in the United States and Canada from 2016 to 2020. Materials and methods: In vitro broth microdilution susceptibility testing for minimal inhibitory concentration values were performed using ten antimicrobial agents (ampicillin, ceftiofur, danofloxacin, enrofloxacin, florfenicol, penicillin, tetracycline, tilmicosin, trimethoprim-sulfamethoxazole, and tulathromycin) with A pleuropneumoniae (n = 250), B bronchiseptica (n = 602), P multocida (n = 874), and S suis (n = 1223) following methods and susceptibility breakpoints approved by the Clinical and Laboratory Standards Institute. Results: Actinobacillus pleuropneumoniae isolates were 100% susceptible to ceftiofur, florfenicol, and tulathromycin and P multocida isolates were 100% susceptible to ceftiofur. High rates of susceptibility (95% to > 99%) were observed for A pleuropneumoniae to tilmicosin; for P multocida to ampicillin, enrofloxacin, florfenicol, penicillin, tilmicosin, and tulathromycin; for S suis to ampicillin and florfenicol; and for B bronchiseptica to tulathromycin. Tetracycline exhibited low susceptibility rates against A pleuropneumoniae (0% to 10.6%), P multocida (23.2% to 38.2%), and S suis (0.8% to 2.1%). No susceptibility of B bronchiseptica to ampicillin (0%) and low rates of susceptibility to florfenicol (3.9% to 15.2%) were also observed. Implications: Under the conditions of this study, the predominant pathogens associated with swine respiratory disease in the United States and Canada, A pleuropneumoniae, B bronchiseptica, P multocida, and S suis collected during 2016 to 2020, display high rates of susceptibility to most veterinary antimicrobial agents.","PeriodicalId":17095,"journal":{"name":"Journal of Swine Health and Production","volume":" ","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2022-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, and Streptococcus suis isolated from diseased pigs in the United States and Canada, 2016 to 2020\",\"authors\":\"M. Sweeney, Lacie A Gunnett, D. Mohan Kumar, B. Lunt, Lucina Galina Pantoja, D. Bade, Chandra M. Machin\",\"doi\":\"10.54846/jshap/1282\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To report the in vitro susceptibility to veterinary antimicrobial agents of Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, and Streptococcus suis isolated from diseased pigs in the United States and Canada from 2016 to 2020. Materials and methods: In vitro broth microdilution susceptibility testing for minimal inhibitory concentration values were performed using ten antimicrobial agents (ampicillin, ceftiofur, danofloxacin, enrofloxacin, florfenicol, penicillin, tetracycline, tilmicosin, trimethoprim-sulfamethoxazole, and tulathromycin) with A pleuropneumoniae (n = 250), B bronchiseptica (n = 602), P multocida (n = 874), and S suis (n = 1223) following methods and susceptibility breakpoints approved by the Clinical and Laboratory Standards Institute. Results: Actinobacillus pleuropneumoniae isolates were 100% susceptible to ceftiofur, florfenicol, and tulathromycin and P multocida isolates were 100% susceptible to ceftiofur. High rates of susceptibility (95% to > 99%) were observed for A pleuropneumoniae to tilmicosin; for P multocida to ampicillin, enrofloxacin, florfenicol, penicillin, tilmicosin, and tulathromycin; for S suis to ampicillin and florfenicol; and for B bronchiseptica to tulathromycin. Tetracycline exhibited low susceptibility rates against A pleuropneumoniae (0% to 10.6%), P multocida (23.2% to 38.2%), and S suis (0.8% to 2.1%). No susceptibility of B bronchiseptica to ampicillin (0%) and low rates of susceptibility to florfenicol (3.9% to 15.2%) were also observed. Implications: Under the conditions of this study, the predominant pathogens associated with swine respiratory disease in the United States and Canada, A pleuropneumoniae, B bronchiseptica, P multocida, and S suis collected during 2016 to 2020, display high rates of susceptibility to most veterinary antimicrobial agents.\",\"PeriodicalId\":17095,\"journal\":{\"name\":\"Journal of Swine Health and Production\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2022-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Swine Health and Production\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.54846/jshap/1282\",\"RegionNum\":4,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Agricultural and Biological Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Swine Health and Production","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.54846/jshap/1282","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Agricultural and Biological Sciences","Score":null,"Total":0}
Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, and Streptococcus suis isolated from diseased pigs in the United States and Canada, 2016 to 2020
Objective: To report the in vitro susceptibility to veterinary antimicrobial agents of Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, and Streptococcus suis isolated from diseased pigs in the United States and Canada from 2016 to 2020. Materials and methods: In vitro broth microdilution susceptibility testing for minimal inhibitory concentration values were performed using ten antimicrobial agents (ampicillin, ceftiofur, danofloxacin, enrofloxacin, florfenicol, penicillin, tetracycline, tilmicosin, trimethoprim-sulfamethoxazole, and tulathromycin) with A pleuropneumoniae (n = 250), B bronchiseptica (n = 602), P multocida (n = 874), and S suis (n = 1223) following methods and susceptibility breakpoints approved by the Clinical and Laboratory Standards Institute. Results: Actinobacillus pleuropneumoniae isolates were 100% susceptible to ceftiofur, florfenicol, and tulathromycin and P multocida isolates were 100% susceptible to ceftiofur. High rates of susceptibility (95% to > 99%) were observed for A pleuropneumoniae to tilmicosin; for P multocida to ampicillin, enrofloxacin, florfenicol, penicillin, tilmicosin, and tulathromycin; for S suis to ampicillin and florfenicol; and for B bronchiseptica to tulathromycin. Tetracycline exhibited low susceptibility rates against A pleuropneumoniae (0% to 10.6%), P multocida (23.2% to 38.2%), and S suis (0.8% to 2.1%). No susceptibility of B bronchiseptica to ampicillin (0%) and low rates of susceptibility to florfenicol (3.9% to 15.2%) were also observed. Implications: Under the conditions of this study, the predominant pathogens associated with swine respiratory disease in the United States and Canada, A pleuropneumoniae, B bronchiseptica, P multocida, and S suis collected during 2016 to 2020, display high rates of susceptibility to most veterinary antimicrobial agents.
期刊介绍:
The Journal of Swine Health & Production (JSHAP) is an open-access and peer-reviewed journal published by the American Association of Swine Veterinarians (AASV) since 1993. The aim of the journal is the timely publication of peer-reviewed papers with a scope that encompasses the many domains of applied swine health and production, including the diagnosis, treatment, management, prevention and eradication of swine diseases, welfare & behavior, nutrition, public health, epidemiology, food safety, biosecurity, pharmaceuticals, antimicrobial use and resistance, reproduction, growth, systems flow, economics, and facility design. The journal provides a platform for researchers, veterinary practitioners, academics, and students to share their work with an international audience. The journal publishes information that contains an applied and practical focus and presents scientific information that is accessible to the busy veterinary practitioner as well as to the research and academic community. Hence, manuscripts with an applied focus are considered for publication, and the journal publishes original research, brief communications, case reports/series, literature reviews, commentaries, diagnostic notes, production tools, and practice tips. All manuscripts submitted to the Journal of Swine Health & Production are peer-reviewed.